Scientists to test drugs for 3 autism-related conditions

12/4/2008 | MIT Technology Review

Researchers plan to conduct human trials of three medications to explore their potential in treating rare, genetic disorders associated with autism -- fragile X, Rett syndrome and tuberous sclerosis complex. One of the studies will test whether chemically triggering a pathway called insulin-like growth factor in Rett syndrome patients is effective at inducing undeveloped synapses to mature.

View Full Article in:

MIT Technology Review

Published in Brief:

SmartBrief Job Listings for Education

Job Title Company Location
San Francisco Unified is Accepting Applications for 2015-16!
San Francisco Unified School District
San Francisco, CA
Director of Professional Services
Engaging Schools, Inc.
Cambridge, MA
Principal at Emerson Academy of Dayton
National Heritage Academies
Dayton, OH
Program Officer, Teacher Development
Knowles Science Teaching Foundation
Moorestown, NJ
Senior Researcher (8194)
American Institute for Researcher
Washington, DC